AHKSY:OTC-Asahi Kaisei Corp (USD)

COMMON STOCK | Chemicals | OTC

Last Closing Price

USD 14.56

Change

-0.08 (-0.55)%

Market Cap

USD 10.17B

Volume

0.05M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


AHKSY Stock Forecast & Price:
Based on the Asahi Kaisei Corp stock forecasts from 0 analysts, the average analyst target price for Asahi Kaisei Corp is not available over the next 12 months. Asahi Kaisei Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Asahi Kaisei Corp is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, Asahi Kaisei Corp’s stock price was USD 14.56. Asahi Kaisei Corp’s stock price has changed by +0.07% over the past week, +12.17% over the past month and -24.01% over the last year.

No recent analyst target price found for Asahi Kaisei Corp
No recent average analyst rating found for Asahi Kaisei Corp

About Asahi Kaisei Corp (AHKSY:OTC)

Asahi Kasei Corporation manufactures, processes, and sells chemical products in Japan and internationally. The company operates through three segments: Material, Homes, and Health Care. It provides caustic soda, chemical fertilizers, nitric acid, ammonia, acrylonitrile, methyl me ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-11-29 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SHECF Shin-Etsu Chemical Co. Ltd

-3.80 (-2.94%)

USD52.21B 11.01 0.04
SHECY Shin-Etsu Chemical Co Ltd ADR

-0.23 (-0.73%)

USD50.71B 10.80 0.04
BFFAF BASF SE NA O.N.

-0.09 (-0.18%)

USD47.42B 8.72 5.76
BASFY BASF SE ADR

+0.12 (+0.95%)

USD47.35B 8.75 5.68
SLMNP A. Schulman Inc

+1.00 (+0.12%)

USD25.11B 935.16 N/A
GNENF Ganfeng Lithium Co Ltd

+0.24 (+3.01%)

USD20.91B 7.00 1.00
GNENY Ganfeng Lithium Co. Ltd

N/A

USD20.91B 7.05 1.00
SOLVY Solvay SA

N/A

USD13.67B 17.30 16.78
SVYSF Solvay SA

+0.48 (+0.50%)

USD10.60B 5.21 4.00
SLVYY Solvay SA ADR

-0.26 (-2.60%)

USD10.60B 5.50 4.00

ETFs Containing AHKSY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.51% 62% D- 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.51% 54% F 52% F
Trailing 12 Months  
Capital Gain -22.14% 70% C- 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.14% 62% D- 54% F
Trailing 5 Years  
Capital Gain -42.29% 63% D 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -42.29% 59% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain -7.88% 26% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.88% 21% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 27.71% 66% D 72% C-
Risk Adjusted Return -28.43% 29% F 20% F
Market Capitalization 10.17B 82% B- 90% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.54 30% F 51% F
Price/Book Ratio 0.75 70% C- 71% C-
Price / Cash Flow Ratio 0.06 53% F 46% F
EV/EBITDA 0.04 56% F 46% F
Management Effectiveness  
Return on Equity 7.04% 36% F 59% F
Return on Invested Capital 6.61% 48% F 62% D-
Return on Assets 3.25% 56% F 73% C
Debt to Equity Ratio 24.52% 65% D 52% F
Technical Ratios  
Dividend Yield 3.53% 33% F 47% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.86 65% D 49% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector